Vikas Bhardwaj

2.4k total citations
37 papers, 861 citations indexed

About

Vikas Bhardwaj is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Vikas Bhardwaj has authored 37 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Vikas Bhardwaj's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Synthesis and biological activity (3 papers). Vikas Bhardwaj is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Synthesis and biological activity (3 papers). Vikas Bhardwaj collaborates with scholars based in United States, India and China. Vikas Bhardwaj's co-authors include Jun He, Alok Bhushan, K. R. Aneja, Om Prakash, James C. K. Lai, Aditi Jain, Parikshit Tyagi, Ravi Kumar, James W. Welsh and María Angélica Cortez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Vikas Bhardwaj

34 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikas Bhardwaj United States 18 427 266 181 172 85 37 861
Yulia Maxuitenko United States 16 479 1.1× 119 0.4× 179 1.0× 122 0.7× 36 0.4× 46 775
Mo Chen China 17 359 0.8× 209 0.8× 156 0.9× 177 1.0× 84 1.0× 50 932
Hong‐Quan Duong Vietnam 19 409 1.0× 173 0.7× 398 2.2× 128 0.7× 71 0.8× 44 851
Boshi Sun China 13 349 0.8× 152 0.6× 138 0.8× 47 0.3× 95 1.1× 24 674
Pierre Bischoff France 19 455 1.1× 122 0.5× 336 1.9× 220 1.3× 92 1.1× 39 1.0k
Lu Zhou China 17 314 0.7× 127 0.5× 133 0.7× 84 0.5× 82 1.0× 50 683
Liyan Chen China 18 581 1.4× 164 0.6× 160 0.9× 55 0.3× 40 0.5× 33 851
Anne Zuse Canada 10 410 1.0× 101 0.4× 134 0.7× 94 0.5× 78 0.9× 11 698
Yi‐Jen Liao Taiwan 19 385 0.9× 222 0.8× 139 0.8× 56 0.3× 74 0.9× 60 911

Countries citing papers authored by Vikas Bhardwaj

Since Specialization
Citations

This map shows the geographic impact of Vikas Bhardwaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Bhardwaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Bhardwaj more than expected).

Fields of papers citing papers by Vikas Bhardwaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas Bhardwaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Bhardwaj. The network helps show where Vikas Bhardwaj may publish in the future.

Co-authorship network of co-authors of Vikas Bhardwaj

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas Bhardwaj. A scholar is included among the top collaborators of Vikas Bhardwaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas Bhardwaj. Vikas Bhardwaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bhardwaj, Vikas, Jun He, & Aditi Jain. (2022). Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity. Medical Oncology. 39(12). 227–227. 4 indexed citations
3.
Jain, Aditi & Vikas Bhardwaj. (2021). Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities. World Journal of Gastroenterology. 27(39). 6527–6550. 31 indexed citations
4.
Sharma, Neha, Alok Bhushan, Jun He, Gagan Kaushal, & Vikas Bhardwaj. (2020). Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase. SHILAP Revista de lepidopterología. 8(1). 19–19. 28 indexed citations
5.
He, Jun, Weitao Liu, Xin Ge, et al.. (2019). Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation. Toxicology and Applied Pharmacology. 378. 114606–114606. 22 indexed citations
6.
Kamal, Raj, Ravinder Kumar, Vipan Kumar, & Vikas Bhardwaj. (2019). Synthetic Utilization of α,β‐Chalcone Dibromide In Heterocyclic Chemistry and Stereoselective Debromination. ChemistrySelect. 4(39). 11578–11603. 14 indexed citations
7.
Kamal, Raj, Vipan Kumar, Ravinder Kumar, et al.. (2017). Design, Synthesis, and Screening of Triazolopyrimidine–Pyrazole Hybrids as Potent Apoptotic Inducers. Archiv der Pharmazie. 350(11). 19 indexed citations
8.
Bhardwaj, Vikas, Liudmila V. Yermalitskaya, Kay Washington, et al.. (2017). Activation of NADPH oxidases leads to DNA damage in esophageal cells. Scientific Reports. 7(1). 9956–9956. 25 indexed citations
9.
Cortez, María Angélica, David R. Valdecanas, Xiaochun Zhang, et al.. (2014). Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer. Molecular Therapy. 22(8). 1494–1503. 162 indexed citations
10.
Bhardwaj, Vikas, Tina Cascone, María Angélica Cortez, et al.. (2013). Modulation of c‐Met signaling and cellular sensitivity to radiation. Cancer. 119(10). 1768–1775. 41 indexed citations
11.
Zaika, Elena, Vikas Bhardwaj, Jinxiong Wei, et al.. (2013). Proinflammatory Cytokines and Bile Acids Upregulate ΔNp73 Protein, an Inhibitor of p53 and p73 Tumor Suppressors. PLoS ONE. 8(5). e64306–e64306. 11 indexed citations
12.
Bhardwaj, Vikas, Satya Murthy Tadinada, Aditi Jain, et al.. (2013). Biochanin A reduces pancreatic cancer survival and progression. Anti-Cancer Drugs. 25(3). 296–302. 35 indexed citations
13.
Bhardwaj, Vikas, Yanai Zhan, María Angélica Cortez, et al.. (2012). C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non–Small-Cell Lung Cancer Cells With Radiation-Induced c-Met–Expression. Journal of Thoracic Oncology. 7(8). 1211–1217. 38 indexed citations
14.
Agrawal, Mayank, et al.. (2011). Use of Technetium99m–ciprofloxacin scan in Pott’s spine to assess the disease activity. International Orthopaedics. 36(2). 271–276. 4 indexed citations
15.
Bhardwaj, Vikas, et al.. (2010). Evaluation of adequacy of short-course chemotherapy for extraspinal osteoarticular tuberculosis using 99mTc ciprofloxacin scan. International Orthopaedics. 35(12). 1869–1874. 11 indexed citations
16.
Bhardwaj, Vikas, et al.. (2008). Iodoacetate and 3-bromopyruvate modulate cell signaling to decrease the pancreatic cancer cell survival. Cancer Research. 68. 4336–4336.
17.
18.
Panchagnula, Ramesh, Manthena V. S. Varma, Vikas Bhardwaj, et al.. (2004). Fixed dose combinations for tuberculosis: Lessons learned fromclinical, formulation and regulatory perspective. Methods and Findings in Experimental and Clinical Pharmacology. 26(9). 703–703. 26 indexed citations
19.
Prakash, Om, Vikas Bhardwaj, Ravi Kumar, Parikshit Tyagi, & K. R. Aneja. (2004). Organoiodine (III) mediated synthesis of 3-aryl/hetryl-5,7-dimethyl-1,2,4-triazolo[4,3-a]pyrimidines as antibacterial agents. European Journal of Medicinal Chemistry. 39(12). 1073–1077. 97 indexed citations
20.
Prakash, Om, et al.. (2003). SYNTHESIS OF SOME NEW 3-ARYL-1-( 4,6-DIMETHYL-2-PYRIMIDINYL)-4-FORMYLPYRAZOLES USING VILSMEIER HAACK REACTION. Heterocyclic Communications. 9(5). 515–518. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yulia Maxuitenko Breakdown of academic impact, for papers by Mo Chen Breakdown of academic impact, for papers by Hong‐Quan Duong Breakdown of academic impact, for papers by Boshi Sun Breakdown of academic impact, for papers by Pierre Bischoff Breakdown of academic impact, for papers by Lu Zhou Breakdown of academic impact, for papers by Liyan Chen Breakdown of academic impact, for papers by Anne Zuse Breakdown of academic impact, for papers by Yi‐Jen Liao
Rankless by CCL
2026